Wang Hui, Wang Yanan, Qian Liu, Wang Xue, Gu Hailiang, Dong Xiaoqiang, Huang Shiqian, Jin Min, Ge Hailiang, Xu Congfeng, Zhang Yanyun
Shanghai Institute of Immunology, Institutes of Medical Sciences, Shanghai Jiao Tong University School of Medicine (SJTUSM) and Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences & SJTUSM, Shanghai, China.
Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Oncotarget. 2016 Aug 9;7(32):51174-51183. doi: 10.18632/oncotarget.9433.
Originally identified as an E3 ligase regulating toll-like receptor (TLR) signaling, ring finger protein 216 (RNF216) also plays an essential role in autophagy, which is fundamental to cellular homeostasis. Autophagy dysfunction leads to an array of pathological events, including tumor formation. In this study, we found that RNF216 was upregulated in human colorectal cancer (CRC) tissues and cell lines, and was associated with progression of CRC. RNF216 promoted CRC cell proliferation and migration in vitro and in vivo, largely by enhancing proteasomal degradation of BECN1, a key autophagy regulator and tumor suppressor. RNF216 restricted CRC cell autophagy through BECN1 inhibition under nutritional starvation conditions. RNF216 knockdown increased the autophagy, limiting CRC cell proliferation and migration. Moreover, BECN1 knockdown or autophagy inhibition restored proliferation and migration of RNF216-knockdown CRC cells. Collectively, our results suggested that RNF216 promoted CRC cell proliferation and migration by negatively regulating BECN1-dependent autophagy. This makes RNF216 as a potential biomarker and novel therapeutic target for inhibiting CRC development and progression.
环指蛋白216(RNF216)最初被鉴定为一种调节Toll样受体(TLR)信号传导的E3连接酶,它在自噬中也起着至关重要的作用,而自噬是细胞稳态的基础。自噬功能障碍会导致一系列病理事件,包括肿瘤形成。在本研究中,我们发现RNF216在人类结直肠癌(CRC)组织和细胞系中上调,且与CRC的进展相关。RNF216在体外和体内均促进CRC细胞增殖和迁移,主要是通过增强关键自噬调节因子和肿瘤抑制因子BECN1的蛋白酶体降解。在营养饥饿条件下,RNF216通过抑制BECN1来限制CRC细胞自噬。敲低RNF216可增加自噬,限制CRC细胞增殖和迁移。此外,敲低BECN1或抑制自噬可恢复敲低RNF216后的CRC细胞的增殖和迁移。总的来说,我们的结果表明,RNF216通过负向调节BECN1依赖性自噬来促进CRC细胞增殖和迁移。这使得RNF216成为抑制CRC发展和进展的潜在生物标志物和新型治疗靶点。